Sign in

CIK 0001253689

  • Non-accelerated filer
  • Smaller reporting company

CRESCENT BIOPHARMA, INC.

Sign in to watch
Ticker
CBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Operating
Phone
+1 617-430-5595
Business address
300 FIFTH AVENUE, WALTHAM, MA, 02451
Former names
GLYCOMIMETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$285,501
in 7 filings, $286K under 10b5-1 plans

Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-21 Rock Edwin Chief Medical Officer Purchase +115,000 $0.27 $31K 680,403
2024-06-20 Rock Edwin Chief Medical Officer Purchase +190,000 $0.25 $48K 565,403
2024-01-12 Rock Edwin Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +250,000 250,000
2023-09-22 Rock Edwin Chief Medical Officer Purchase +30,403 $1.38 $42K 375,403
2023-09-21 Rock Edwin Chief Medical Officer Purchase +35,000 $1.38 $48K 345,000
2023-01-19 Rock Edwin Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +244,800 244,800
2022-12-22 Rock Edwin Chief Medical Officer Purchase +110,000 $2.25 $248K 310,000
2022-11-15 Rock Edwin Chief Medical Officer Purchase +100,000 $1.66 $166K 200,000
2022-11-14 Rock Edwin Chief Medical Officer Purchase +100,000 $1.43 $143K 100,000
2022-09-02 Rock Edwin Chief Medical Officer Grant or award · Employee stock option (right to buy) +200,000 200,000

Page 1 of 1 · 10 trades